BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2249889)

  • 1. Mitogenic peptides in breast cyst fluid: relationship with intracystic electrolyte ratios.
    Lai LC; Ghatei MA; Takahashi K; Patel KV; Schrey MP; Ghilchik MW; Bloom SR; James VH
    Int J Cancer; 1990 Dec; 46(6):1014-6. PubMed ID: 2249889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content.
    Boccardo F; Valenti G; Zanardi S; Cerruti G; Fassio T; Bruzzi P; De Franchis V; Barreca A; Del Monte P; Minuto F
    Cancer Res; 1988 Oct; 48(20):5860-3. PubMed ID: 2971432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor and oestradiol in human breast cyst fluid.
    Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; Shaikh NA; James VH
    Eur J Cancer; 1990 Apr; 26(4):481-4. PubMed ID: 2141515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between epidermal growth factor and dehydroepiandrosterone and its sulphate in breast cyst fluid.
    Lai LC; Ghilchik MW; Shaikh NA; Reed MJ; James VH
    Br J Cancer; 1989 Sep; 60(3):320-3. PubMed ID: 2528985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oestradiol and epidermal growth factor in breast cyst fluid.
    Lai LC; Dunkley SA; Reed MJ; Ghilchik MW; James VH
    Anticancer Res; 1989; 9(6):1853-6. PubMed ID: 2627131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of immunoassayable transforming growth factor-beta 1 (TGF-beta 1) in breast cyst fluid (BCF): relationship with the intracystic electrolyte and epidermal-growth-factor (EGF) content.
    Zanardi S; Pensa F; Torrisi R; De Franchis V; Barreca A; Minuto F; Boccardo F
    Int J Cancer; 1994 Dec; 59(6):725-7. PubMed ID: 7989108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor content of breast cyst fluids from women with breast cancer or proliferative disease of the breast.
    Torrisi R; Zanardi S; Pensa F; Valenti G; De Franchis V; Nicolo G; Barreca A; Minuto F; Boccardo F
    Breast Cancer Res Treat; 1995 Mar; 33(3):219-24. PubMed ID: 7749149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presence of epidermal growth factor receptor in breast smears of cyst fluids: relationship to electrolyte ratios and pH concentration.
    Athanassiadou PP; Veneti SZ; Kyrkou KA; Intzes KS; Mouzaka LI; Papadimitriou GK
    Cancer Detect Prev; 1992; 16(2):113-8. PubMed ID: 1600520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor alpha, beta 1 and beta 2 in breast cyst fluid.
    Lai LC; Siraj AK; Erbas H; Lennard TW
    Anticancer Res; 1994; 14(6B):2805-9. PubMed ID: 7872722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between oestrogen-inducible proteins, oestradiol and electrolyte ratio in breast cyst fluid.
    Lai LC; Cornell C; Lennard TW
    Cancer Lett; 1993 Apr; 69(1):21-5. PubMed ID: 8481890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncostatin M, interleukin 2, interleukin 6 and interleukin 8 in breast cyst fluid.
    Lai LC; Kadory S; Siraj AK; Lennard TW
    Int J Cancer; 1994 Nov; 59(3):369-72. PubMed ID: 7927943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracystic epidermal growth factor level is predictive of breast-cancer risk in women with gross cystic disease of the breast.
    Boccardo F; Marenghi C; Ghione G; Pepe A; Parodi S; Rubagotti A
    Int J Cancer; 2001 Jul; 95(4):260-5. PubMed ID: 11400120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour necrosis factor-alpha and interleukin-1 and -6 in fibrocystic breast disease.
    Herruzo A; Castilla JA; Ramírez A; Marcos C; Menjón S
    Breast Cancer Res Treat; 1999 Mar; 54(2):159-64. PubMed ID: 10424406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of soluble vascular cell adhesion molecule-1 and E-selectin in breast cyst fluid and their relation with cyst type.
    Lai LC; Siraj AK; Kadory S; Lennard TW
    Br J Surg; 1995 Jan; 82(1):83-5. PubMed ID: 7533629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibitory substances in human breast cyst fluid.
    Lai LC; Chan CT; Cornell C; Lennard TW
    Anticancer Res; 1993; 13(1):225-7. PubMed ID: 8476217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-antichymotrypsin complexes in human breast cyst fluids.
    Mannello F; Malatesta M; Bocchiotti G; Gazzanelli G
    Cancer Lett; 1994 Jan; 76(2-3):155-9. PubMed ID: 8149344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterolactone in breast cyst fluid: correlation with EGF and breast cancer risk.
    Boccardo F; Lunardi GL; Petti AR; Rubagotti A
    Breast Cancer Res Treat; 2003 May; 79(1):17-23. PubMed ID: 12779078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible regulation of soluble ICAM-1 levels by interleukin-1 in a sub-set of breast cysts.
    Lai LC; Kadory S; Cornell C; Lennard TW
    Int J Cancer; 1993 Oct; 55(4):586-9. PubMed ID: 8406986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor binding protein-3 in breast cyst fluid: relationships with insulin-like growth factors I and II and transforming growth factor-beta 1 and 2.
    Lai LC; Erbas H; Meadows KA; Lennard TW; Holly JM
    Cancer Lett; 1996 Dec; 110(1-2):207-12. PubMed ID: 9018103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships of Na+ and K+ concentrations to GRP, CGRP, and calcitonin immunoreactivities and Na+,K(+)-ATPase (NKA) inhibitory activity in human breast cyst fluid.
    Weber CJ; Kim D; Costanzo M; Morris J; Howe B; Ward L; D'Agati V; McDonald T; O'Dorisio TM; Butler VP
    Ann Surg Oncol; 1994 Jul; 1(4):339-44. PubMed ID: 7850533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.